4//SEC Filing
OBOYLE KEVIN C 4
Accession 0001790300-20-000004
CIK 0001492658other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 3:51 PM ET
Size
25.3 KB
Accession
0001790300-20-000004
Insider Transaction Report
Form 4
OBOYLE KEVIN C
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2020-11-11−11,691→ 0 totalExercise: $27.84Exp: 2029-07-26→ Ordinary Shares (11,691 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−11,018→ 0 totalExercise: $20.62Exp: 2025-10-13→ Ordinary Shares (11,018 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−7,800→ 0 totalExercise: $25.20Exp: 2021-05-12→ Ordinary Shares (7,800 underlying) - Disposition from Tender
Ordinary Shares, par value EUR 0.03 per share
2020-11-11$30.75/sh−16,306$501,410→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−9,907→ 0 totalExercise: $24.49Exp: 2028-07-24→ Ordinary Shares (9,907 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−10,275→ 0 totalExercise: $27.86Exp: 2027-07-25→ Ordinary Shares (10,275 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−6,034→ 0 totalExercise: $21.66Exp: 2024-08-12→ Ordinary Shares (6,034 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−7,538→ 0 totalExercise: $19.45Exp: 2023-08-09→ Ordinary Shares (7,538 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−6,448→ 0 totalExercise: $18.04Exp: 2022-08-10→ Ordinary Shares (6,448 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-11-11−11,765→ 0 totalExercise: $21.24Exp: 2026-07-19→ Ordinary Shares (11,765 underlying)
Footnotes (2)
- [F1]On November 4, 2019, Wright Medical Group N.V. (the "Issuer") entered into a purchase agreement (the "Purchase Agreement") with Stryker Corporation and its subsidiary, Stryker B.V. (the "Purchaser"). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share ("Shares"), of the Issuer (the "Offer"), and, on November 11, 2020 (the "Acceptance Time"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 26,063 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the "Offer Consideration"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).
- [F2]Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Documents
Issuer
Wright Medical Group N.V.
CIK 0001492658
Entity typeother
Related Parties
1- filerCIK 0001203567
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 3:51 PM ET
- Size
- 25.3 KB